Swedish Orphan Biovitrum AB (BIOVF) Q3 2024 Earnings Call Highlights: Robust Growth and ...

By Yahoo! Finance | Oct 25, 2024 at 05:02 AM EST

Guido Oelkers highlighted a 6% market share gain in Germany for hemophilia in a short period due to switches from competitors, showing promise for similar success in other European markets. Majority of Altuviiio patients switched from Elocta, with no stocking effect.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.